In nephrology, differential diagnosis or assessment of disease activity largely relies on the
analysis of glomerular filtration rate, urinary sediment, proteinuria and tissue obtained …

Kidney disease is a leading cause of morbidity and mortality across the globe. Current
interventions for kidney disease include dialysis and renal transplantation, which have …

Kidney disease management and treatment are currently causing a substantial global
burden. The kidneys are the most important organs in the human urinary system, selectively …

Kidney disease affects more than 10% of the global population and is associated with
considerable morbidity and mortality, highlighting a need for new therapeutic options …

Renal cell carcinoma (RCC) is one of the most common kidney cancers, responsible for
nearly 90% of all renal malignancies. Despite the availability of many treatment strategies …

Nanomedicine is currently showing great promise for new methods of diagnosing and
treating many diseases, particularly in kidney disease and transplantation. The unique …

Renal cell carcinoma (RCC) records for 2% of all cancer assessments and mortality
worldwide, and its severity has more than doubled in the world over the last half-century …

Urologic cancers, particularly kidney, bladder, and prostate cancer, have a growing
incidence and account for about a million annual deaths worldwide. Treatments, including …

Clear cell renal cell carcinoma (ccRCC) is a heterogeneous malignancy with poor
prognosis. Methylation of the N 6 position of adenosine (m 6 A), the most common …

Targeted delivery of therapeutics through the use of nanoparticles (NPs) has emerged as a
promising method that increases their efficacy and reduces their side effects. NPs can be …